GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genoray Co Ltd (XKRX:122310) » Definitions » EV-to-FCF

Genoray Co (XKRX:122310) EV-to-FCF : 10.95 (As of Apr. 16, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Genoray Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Genoray Co's Enterprise Value is ₩76,474 Mil. Genoray Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was ₩6,982 Mil. Therefore, Genoray Co's EV-to-FCF for today is 10.95.

The historical rank and industry rank for Genoray Co's EV-to-FCF or its related term are showing as below:

XKRX:122310' s EV-to-FCF Range Over the Past 10 Years
Min: -6503.81   Med: 25.26   Max: 183.12
Current: 10.77

During the past 13 years, the highest EV-to-FCF of Genoray Co was 183.12. The lowest was -6503.81. And the median was 25.26.

XKRX:122310's EV-to-FCF is ranked better than
73.83% of 107 companies
in the Medical Diagnostics & Research industry
Industry Median: 22.67 vs XKRX:122310: 10.77

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-16), Genoray Co's stock price is ₩5320.00. Genoray Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-137.000. Therefore, Genoray Co's PE Ratio (TTM) for today is At Loss.


Genoray Co EV-to-FCF Historical Data

The historical data trend for Genoray Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genoray Co EV-to-FCF Chart

Genoray Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.34 18.87 88.52 -58.74 11.49

Genoray Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -58.74 57.17 25.21 32.03 11.49

Competitive Comparison of Genoray Co's EV-to-FCF

For the Diagnostics & Research subindustry, Genoray Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genoray Co's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genoray Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Genoray Co's EV-to-FCF falls into.


;
;

Genoray Co EV-to-FCF Calculation

Genoray Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=76474.222/6981.946
=10.95

Genoray Co's current Enterprise Value is ₩76,474 Mil.
Genoray Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩6,982 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genoray Co  (XKRX:122310) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Genoray Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=5320.00/-137.000
=At Loss

Genoray Co's share price for today is ₩5320.00.
Genoray Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-137.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Genoray Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Genoray Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Genoray Co Business Description

Traded in Other Exchanges
N/A
Address
No. 512, 560, Dunchon-daero, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 462-716
Genoray Co Ltd manufactures and sells medical and dental systems in South Korea. The company has developed the 3DCT software for medical and dental applications and developed innovative 3D software for dentistry. The product portfolio includes OSCAR prime, ZEN-7000, MX-600, PORT-X II, PORT-X IV, and PAPAYA.

Genoray Co Headlines

No Headlines